Brain cancer: Typical mutation in cancer cells stifles immune response

(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) The exchange of a single amino acid building block in a metabolic enzyme can lead to cancer. In addition, it can impair the immune system, scientists from the German Cancer Research Center (DKFZ), the University Hospitals in Mannheim and Heidelberg, and the German Cancer Consortium now report. It thus blocks the body's immune response in the battle against the mutant molecule and also impedes immunotherapy against brain cancer. This findingsuggests that rethinking antitumor immunotherapy is required.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news